FDA Approved and Recalled drugs from Jan 2012 to May 2012

FDA-Approved Drugs in 2012

Dermatology/Plastic Surgery

Sklice (ivermectin) lotion; Sanofi Pasteur; For the treatment of head lice, Approved February 2012


Korlym (mifepristone); Corcept Therapeutics; For the control of hyperglycemia in adults with endogenous Cushing’s syndrome, Approved February 2012


Elelyso (taliglucerasealfa); Pfizer Inc; For the treatment of Gaucher disease, Approved May 2012

Omontys (peginesatide); Affymax; For the treatment of anemia due to chronic kidney disease, Approved March 2012


Stendra (avanafil); Vivus; For the treatment of erectile dysfunction, Approved April 2012


Afinitor (everolimus); Novartis Pharmaceuticals Corporation; For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex, Approved April 2012

Erivedge (vismodegib); Genentech; For the treatment of basal cell carcinoma, Approved January 2012

Inlyta (axitinib); Pfizer; For the treatment of advanced renal cell carcinoma, Approved January 2012


click here for more

[gview file=”http://pharmawiki.in/wp-content/uploads/2012/06/FDA-2012-Newly-approved-drugs-imp-for-niper-jee.pdf”]

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.